Literature DB >> 22311186

Bioinformatic and experimental fishing for artemisinin-interacting proteins from human nasopharyngeal cancer cells.

T Eichhorn1, S Schloissnig, B Hahn, A Wendler, Rolf Mertens, W D Lehmann, R L Krauth-Siegel, T Efferth.   

Abstract

Determining interacting cellular partners of drugs by chemical proteomic techniques is complex and tedious. Most approaches rely on activity-based probe profiling and compound-centric chemical proteomics. The anti-malarial artemisinin also exerts profound anti-cancer activity, but the mechanisms of action are incompletely understood. In the present investigation, we present a novel approach to identify artemisinin-interacting target proteins. Our approach overcomes usual problems in traditional fishing procedures, because the drug was attached to a surface without further chemical modification. The proteins identified effect among others, cell cycle arrest, apoptosis, inhibition of angiogenesis, disruption of cell migration, and modulation of nuclear receptor responsiveness. Furthermore, a bioinformatic approach confirmed experimentally identified proteins and suggested a large number of other interacting proteins. Theoretically predicted interaction partners may serve as a starting point to complete the whole set of proteins binding artemisinin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311186     DOI: 10.1039/c2mb05437j

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  8 in total

1.  25-methoxyl-dammarane-3β, 12β, 20-triol and artemisinin synergistically inhibit MDA-MB-231 cell proliferation through downregulation of testes-specific protease 50 (TSP50) expression.

Authors:  Danfeng Wang; Yuqing Zhao; Yimeng Wang; Yan Rong; Hongshuang Qin; Yongli Bao; Zhenbo Song; Chunlei Yu; Luguo Sun; Yuxin Li
Journal:  Tumour Biol       Date:  2016-04-02

2.  Anticancer properties of distinct antimalarial drug classes.

Authors:  Rob Hooft van Huijsduijnen; R Kiplin Guy; Kelly Chibale; Richard K Haynes; Ingmar Peitz; Gerhard Kelter; Margaret A Phillips; Jonathan L Vennerstrom; Yongyuth Yuthavong; Timothy N C Wells
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

3.  Treatment of Iron-Loaded Veterinary Sarcoma by Artemisia annua.

Authors:  Elmar Breuer; Thomas Efferth
Journal:  Nat Prod Bioprospect       Date:  2014-04-12

4.  Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1.

Authors:  Shu-Yi Yin; Thomas Efferth; Feng-Yin Jian; Yung-Hsiang Chen; Chia-I Liu; Andrew H J Wang; Yet-Ran Chen; Pei-Wen Hsiao; Ning-Sun Yang
Journal:  Oncotarget       Date:  2016-07-12

Review 5.  Target identification of anticancer natural products using a chemical proteomics approach.

Authors:  Swadhapriya Bhukta; Pushparathinam Gopinath; Rambabu Dandela
Journal:  RSC Adv       Date:  2021-08-18       Impact factor: 4.036

6.  Comparative in vitro cytotoxicity and binding investigation of artemisinin and its biogenetic precursors with ctDNA.

Authors:  Neha Maurya; Khalid Imtiyaz; M Moshahid Alam Rizvi; Khaled Mohamed Khedher; Prashant Singh; Rajan Patel
Journal:  RSC Adv       Date:  2020-06-25       Impact factor: 4.036

Review 7.  Antitumor Research on Artemisinin and Its Bioactive Derivatives.

Authors:  Yunqin Zhang; Guowei Xu; Shuqun Zhang; Dong Wang; P Saravana Prabha; Zhili Zuo
Journal:  Nat Prod Bioprospect       Date:  2018-04-09

Review 8.  Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer.

Authors:  Ramon Yarza; Mateo Bover; Maria Teresa Agulló-Ortuño; Lara Carmen Iglesias-Docampo
Journal:  J Exp Clin Cancer Res       Date:  2021-06-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.